Inotec AMD has developed a non-invasive, easy to use technology to heal difficult to treat wounds, such as diabetic and venous ulcers, via its NATROX system. The company is already selling to customers and clinics, and has early-stage revenues across different territories and disease/wound areas.
The NATROX device is straightforward, providing humified oxygen directly to the wound area in the form of a sterile, single-use consumable wound interface that fits inside standard dressings. It has clear, clinically proven benefits over its competition and current standard of care, and could reduce related costs for care providers by up to 60%. MarketsandMarkets predict the global wound care market to be worth $19.8bn in 2020, with estimates forecasting it to rise to $24.8bn by 2024.
Craig Kennedy, CEO, has a proven track record of building businesses in the wound care space and is extremely well regarded in the industry, with over a decade of experience. He led the exit of Moleculight, a wound care device business that returned 4x return for investors.